Home About ATSDR Press Room A-Z Index Glossary Employment Training Contact Us CDC  
ATSDR/DHHS Agency for Toxic Substances and Disease Registry Agency for Toxic Substances and Disease Registry Department of Health and Human Services ATSDR en Español

Search:

Toxic Substances and Health
 
Section Contents
 
Acute Exposure
Chronic Exposure
 
Case Contents
 
Cover Page
Goals and Objectives
Case Study, Pretest
Who is at Risk
Exposure Pathways
Biological Fate
Physiologic Effects
Clinical Evaluation
Standards, Regulations
Suggested Reading
Answers
Sources of Information
 
Case Studies (CSEM)
 
CSEM Home
Continuing Education
Online Registration
 
Related Documents
 
ToxFAQs™
PHS
Toxicological Profile
MMG
Interaction Profile
 
ATSDR Resources
 
Case Studies (CSEM)
Exposure Pathways
GATHER (GIS)
Health Assessments
Health Statements
Interaction Profiles
Interactive Learning
Managing Incidents
Medical Guidelines
Minimal Risk Levels
Priority List
ToxFAQs™
ToxFAQs™ CABS
Toxicological Profiles
Toxicology Curriculum
 
External Resources
 
CDC
eLCOSH
EPA
Healthfinder®
Medline Plus
NCEH
NIEHS
NIOSH
OSHA
 

Agency for Toxic Substances and Disease Registry
Case Studies in Environmental Medicine (CSEM) 

Benzene Toxicity
Treatment and Management


Acute Exposure

  • There is no antidote for acute benzene poisoning.

  • Treatment for benzene toxicity is supportive and symptomatic.

There is no antidote for benzene poisoning; therefore, treatment for persons acutely exposed to benzene is generally supportive and symptomatic. Immediate removal of the patient from exposure, administration of oxygen, and monitoring and treatment of cardiopulmonary status are the first considerations. In cases of ingestion, respiratory distress may indicate pulmonary aspiration of gastric contents.

Contaminated clothing and shoes should be removed from an exposed person as soon as possible. If liquid benzene has contacted the skin or eyes, immediately wash the exposed skin with soap and copious water, and irrigate the eyes with running water for 3 to 5 minutes or until irritation ceases.

In cases of ingestion, do not induce emesis. Care must be taken to avoid aspiration of stomach contents during vomiting because benzene can produce a severe chemical pneumonitis. Ensure that the patient's airway is properly controlled and maintained before initiating orogastric tube lavage. Gastric lavage is indicated if large amounts of benzene have been ingested or if the patient is seen more than 1 hour after ingestion. Activated charcoal may be used; it decreases benzene absorption in experimental animals, and the benefits are likely to be similar in humans. Monitor the cardiac status of the patient: benzene is one of several solvents that may increase the susceptibility of the myocardium to the dysrhythmogenic effects of catecholamines.

Epinephrine should be used only in the setting of cardiac arrest or severe refractory reactive airway disease because its use may lead to ventricular fibrillation secondary to the irritability of the myocardium.


Chronic Exposure

  • Once chronic exposure to benzene ceases, hematologic test results typically return to normal.

In treating persons chronically exposed to benzene, the most important actions are to remove the patient from the source of benzene exposure and to prevent further exposure. Benzene-induced depression of blood elements generally reverses after exposure is terminated. Chronically exposed patients whose hematologic results do not return to normal despite removal from exposure should be managed in consultation with a hematologist or oncologist. Chemotherapy and bone marrow transplants are therapeutic options for leukemia and aplastic anemia, respectively.


Challenge

  1. What are some key considerations in the treatment for the patient in the case study?
  2. What is the prognosis for this patient? What follow-up care should he receive?

Previous Section

Next Section

Revised 2000-06-30.